Specific classification of the chemotherapeutic agent, Vincristine is ?

Chitranjjan National Cancer Institute Kolkata - 2021

Pharmacology

Easy

Appeared in: Chitranjjan National Cancer Institute Kolkata - 2021

Explanation

Vincristine is classified as a mitotic inhibitor, which works by halting cell division (mitosis).
It is a plant alkaloid, specifically a vinca alkaloid, derived from the periwinkle plant.
Its mechanism involves binding to tubulin, which disrupts the formation of the mitotic spindle, arresting the cell in the M-phase of the cell cycle.
This action prevents cancer cells from dividing and leads to their death.

Option A: Hormone modulators, like Tamoxifen, work by blocking or altering hormone receptors. This mechanism is completely different from Vincristine's action on microtubules. Vincristine does not affect hormone pathways.
Option C: Antineoplastic antibiotics, such as Doxorubicin, primarily damage cancer cells by intercalating with DNA or generating free radicals. Vincristine does not act directly on DNA.
Option D: Antimetabolites, like Methotrexate or 5-Fluorouracil, interfere with the synthesis of DNA by acting as false substitutes for normal metabolic building blocks. Vincristine does not mimic metabolic molecules; it targets the physical structures of cell division.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Classification and mechanism of action of chemotherapeutic agents as background academic context rather than a clinical decision trigger.
A critical nursing safety measure is preventing the accidental intrathecal administration of Vincristine, which is fatal. Nurses must adhere to strict protocols, such as ensuring the drug is diluted in a minibag and clearly labeled 'For IV Use Only'.
Nurses must diligently monitor for and manage the key side effects of Vincristine, including peripheral neuropathy (assessing for numbness, tingling, and foot drop) and constipation (implementing a bowel regimen).
What if? If a patient receiving Vincristine reports new-onset tingling in their fingers and toes, the nurse must document this finding and immediately report it to the oncologist. This is an early sign of neurotoxicity, and the dose may need to be adjusted to prevent permanent nerve damage.

How to Approach the Question

First, identify the core of the question, which asks for the classification of the drug 'Vincristine'.
This is a factual recall question common in pharmacology. Access your knowledge base about major chemotherapy drug classes.
Evaluate each option: 'Hormone modulator' relates to hormones, 'Antimetabolite' to cell metabolism, 'Antineoplastic antibiotic' to DNA damage, and 'Mitotic inhibitor' to cell division.
Recall that Vincristine is a 'vinca' alkaloid. The name 'vinca' is a strong clue, but knowing it interferes with the mitotic spindle directly points to it being a mitotic inhibitor.
Select the option that accurately describes this mechanism of action.

Concept Tested & Keywords

Concept Tested: Classification and mechanism of action of chemotherapeutic agents
Stem keywords: Vincristine, chemotherapeutic agent, classification
Lead-in keywords: Specific classification
Negative lead-in flag: false